A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures.

Source:http://linkedlifedata.com/resource/pubmed/id/8952010

Download in:

View as

General Info

PMID
8952010